Successful oral delivery of VEGFR2 also promoted efficient inhibition of tumoral growth and tumor necrosis in a murine B16 melanoma model, due to the suppression of angiogenesis in the tumoral vasculature. The gene discussed is KDR; the disease is neoplasm.